Considerations in the deployment of novel universal vaccines against epidemic and pandemic influenza

N Arinaminpathy, S Riley, W.S Barclay, C Saad-Roy, B Grenfell
doi: https://doi.org/10.1101/19002485

Article Information

doi 
https://doi.org/10.1101/19002485
History 
  • July 29, 2019.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. N Arinaminpathy1,*,
  2. S Riley1,
  3. W.S Barclay2,
  4. C Saad-Roy3 and
  5. B Grenfell4
  1. 1MRC Centre for Global Infectious Disease Analysis, Faculty of Medicine, Imperial College London, UK
  2. 2Department of Infectious Disease, Faculty of Medicine, Imperial College London, UK
  3. 3Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, USA
  4. 4Department of Ecology and Evolutionary Biology, Princeton University, Princeton, USA
  1. ↵*Corresponding author; email: nim.pathy{at}imperial.ac.uk
Back to top
Posted July 29, 2019.
Download PDF
Data/Code
Email
Considerations in the deployment of novel universal vaccines against epidemic and pandemic influenza
N Arinaminpathy, S Riley, W.S Barclay, C Saad-Roy, B Grenfell
medRxiv 19002485; doi: https://doi.org/10.1101/19002485
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area